NGGT-001

N/A

Report date: 2024/12/17 16:59:05

Base Information

Drug NameNGGT-001
Drug Alias NameNGGT001NGGT-001
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV2 vector
Mechanisms of ActionCYP4V2 gene transference
TargetsCytochrome P450 4V2
Therapy Area/IndicationsBietti Crystalline DystrophyRetinal DegenerationRetinal Dysplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesXiamen University
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesXiamen Ophthalmology Center Affiliated To Xiamen UniversitySuzhou Nuojiebei Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsBietti Crystalline DystrophyRetinal DegenerationRetinal Dysplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A